(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Private Equity Industry Banner
Mouse Scroll Icon
August 2023

Kytopen Appoints Michael Chiu as Chief Executive Officer

Kytopen announced the appointment of Michael Chiu as Chief Executive Officer. Before this, he was the Chief Executive Officer of Erbi Biosystems Inc., which was acquired by Merck KGaA, Darmstadt, Germany (MilliporeSigma in the US), last year.

Kytopen is a biotechnology company that develops innovative solutions for cell engineering and gene therapy applications.